CIM Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,744	Closed	-$313K	–	279
2023 Q1	$313K	Buy	4,744 +163	+4%	+$10.8K	0.12%	182
2022 Q4	$237K	Buy	4,581 +1,238	+37%	+$64K	0.09%	200
2022 Q3	$228K	Buy	+3,343	New	+$228K	0.1%	182